Relationship of p53 molecular abnormalities with flow cytometry and growth factor receptor content in lung cancer

This publication has 23 references indexed in Scilit:

• p53 mutations in lung cancers from non-smoking atomic-bomb survivors
  The Lancet, 1993
• Clinical Implications of the p53 Tumor-Suppressor Gene
  New England Journal of Medicine, 1993
• Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma
  International Journal of Cancer, 1993
• Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer
  Carcinogenesis: Integrative Cancer Research, 1993
• Reversible p53 expression in lung cancer
  The Lancet, 1992
• Clinicopathological Significance of Nuclear Accumulation of Tumor Suppressor Gene p53 Product in Primary Lung Cancer
  Japanese Journal of Cancer Research, 1992
• p53 immunostaining in benign breast disease
  The Lancet, 1991
• Relationship Between K-ras Oncogene Activation and Smoking in Adenocarcinoma of the Human Lung
  JNCI Journal of the National Cancer Institute, 1991
• Epidermal growth factor receptor in human breast cancer: Correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics
  European Journal of Cancer and Clinical Oncology, 1990
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976